Back

Cardiotoxicity in haematological diseases: are the tyrosine kinase inhibitors imatinib and nilotinib safe?

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Chronic heart failure (CHF) Cardiotoxicity of drugs ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Ana Francisco

Santa Maria University Hospital (CHULN), Lisbon Academic Medical Centre and Cardiovascular Centre , Lisbon (Portugal)

29 More presentations in this session

Presentation thumbnail
Doctor M. Koga (Osaka, JP)
Abstract
Presentation thumbnail
Doctor P. Kanagala (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Associate Professor S. Caravita (Bergamo, IT)
Abstract
Presentation thumbnail
Doctor K. Keramida (Athens, GR)
Abstract Slides
Presentation thumbnail
Professor P. Leszek (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources